Prenostics tracks precancer status in three new ways.

First we detect levels of key RNA binding proteins in the blood that are secreted by both precancers and cancer cells.

Next, we integrate the results with age and other factors to produce the Prenostics Score. This indicates the likelihood of having a precancer as “low” (normal), “intermediate” (precancer but no cancer present) or “high” (established cancer).

Finally, we provide physicians with a comprehensive Prenostics Report which informs the next steps for both the patient and healthcare team.